Literature DB >> 25695717

MicroRNA-183/182/96 cooperatively regulates the proliferation of colon cancer cells.

Qingquan Zhang1, Wei Ren1, Bin Huang2, Liang Yi1, Hongtao Zhu1.   

Abstract

The microRNA (miR/miRNA)-182/183/96 cluster comprises miR-96, -182 and -183. The present study examined five previous microarray-based human colon cancer miR expression profiling studies and the expression of these three miRs was found to be upregulated in colon cancer tissues. Subsequently, in vitro assays were performed to determine the role of the miR-183/182/96 cluster in colon cancer cells. The results demonstrated that inhibiting miR-183, miR-182 or miR-96 with antisense oligonucleotide (ASO)-mimics inhibited the proliferation of colon cancer cells. Notably, further investigation revealed that inhibiting their expression simultaneously led to a more efficient reduction in cancer cell proliferation. These results suggested that miR-182/183/96, which resides in clusters in the genome, functioned synergistically in colon cancer and implied that co-expression of the miR cluster ASOs was efficient in reducing tumorigenesis, offering novel insight into the use of miRNAs in tumor therapy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25695717     DOI: 10.3892/mmr.2015.3376

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  14 in total

1.  Up-Regulation of microRNA-183 Promotes Cell Proliferation and Invasion in Glioma By Directly Targeting NEFL.

Authors:  Ze-You Wang; Jing Xiong; Shan-Shan Zhang; Jian-Jun Wang; Zhao-Jian Gong; Min-Hui Dai
Journal:  Cell Mol Neurobiol       Date:  2016-02-15       Impact factor: 5.046

2.  Cisplatin and Paclitaxel Alter the Expression Pattern of miR-143/145 and miR-183/96/182 Clusters in T24 Bladder Cancer Cells.

Authors:  Emmanuel I Papadopoulos; Andreas Scorilas
Journal:  Clin Transl Sci       Date:  2015-09-10       Impact factor: 4.689

3.  Wnt/catenin β1/microRNA 183 predicts recurrence and prognosis of patients with colorectal cancer.

Authors:  Yuzhuo Chen; Weiliang Song
Journal:  Oncol Lett       Date:  2018-01-26       Impact factor: 2.967

4.  High miR-96 levels in colorectal adenocarcinoma predict poor prognosis, particularly in patients without distant metastasis at the time of initial diagnosis.

Authors:  Stamatia-Maria Rapti; Christos K Kontos; Iordanis N Papadopoulos; Andreas Scorilas
Journal:  Tumour Biol       Date:  2016-04-04

5.  MicroRNA-183 suppresses cancer stem-like cell properties in EBV-associated nasopharyngeal carcinoma.

Authors:  Chartia Ching-Mei Cheung; Samantha Wei-Man Lun; Grace Tin-Yun Chung; Chit Chow; Carman Lo; Kwong-Wai Choy; Kwok-Wai Lo
Journal:  BMC Cancer       Date:  2016-07-19       Impact factor: 4.430

6.  Induction of miR-96 by Dietary Saturated Fatty Acids Exacerbates Hepatic Insulin Resistance through the Suppression of INSR and IRS-1.

Authors:  Won-Mo Yang; Kyung-Ho Min; Wan Lee
Journal:  PLoS One       Date:  2016-12-30       Impact factor: 3.240

Review 7.  Enhanced Inhibition of Tumorigenesis Using Combinations of miRNA-Targeted Therapeutics.

Authors:  Svetlana Miroshnichenko; Olga Patutina
Journal:  Front Pharmacol       Date:  2019-05-16       Impact factor: 5.988

8.  Molecular expression profiles of selected microRNAs in colorectal adenocarcinoma in patients from south-eastern part of Romania.

Authors:  Costel Brînzan; Mariana Aşchie; Elena Matei; Anca Mitroi; Georgeta Cozaru
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

9.  Antisense oligonucleotides against microRNA-21 reduced the proliferation and migration of human colon carcinoma cells.

Authors:  Yi-Jing Tao; Yong-Ju Li; Wen Zheng; Juan-Juan Zhao; Meng-Meng Guo; Ya Zhou; Na-Lin Qin; Jing Zheng; Lin Xu
Journal:  Cancer Cell Int       Date:  2015-08-01       Impact factor: 5.722

10.  High expression of microRNA-183/182/96 cluster as a prognostic biomarker for breast cancer.

Authors:  Cailu Song; Lijuan Zhang; Jin Wang; Zhongying Huang; Xing Li; Mingqing Wu; Shuaijie Li; Hailin Tang; Xiaoming Xie
Journal:  Sci Rep       Date:  2016-04-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.